Centese has developed technology that transforms the recovery process for patients undergoing cardiothoracic surgery, accelerating healing while minimizing complications. Their system, Thoraguard, is 510(k)-cleared by FDA and has been used on over 4,000 patients to date. Thoraguard is backed by published data showcasing clear clinical and economic benefits and has been enthusiastically endorsed by globally-renowned thoracic surgeons.
